704P Regional differences in drug-induced lung disease (DILD) caused by anticancer drugs between the US, EU and Japan: A large-scale data-based analysis using the FDA Adverse Event... von Sadachi, R., Sato, J., Okada, M.O., Katsuya, Y., Koyama, T., Yamamoto, N.

Volltext

MO59-1 An investigator-initiated phase II trial of tirabrutinib in patients with relapsed or refractory secondary CNS lymphoma von Munakata, W., Goto, H., Fukuhara, N., Nagai, H., Arima, H., Kato, K., Kurishita, K., Shuda, Y., Isomura, R., Ando, Y., Iwaki, N., Sadachi, R., Okita, N., Izutsu, K.

Volltext

1746P Real-world characterization of patients with advanced or metastatic dedifferentiated liposarcoma (DDLPS) in Japan in MASTER KEY project von Tsuchihashi, K., Okuma, H.S., Baba, E., Takahashi, M., Kinoshita, I., Muto, M., Kamikura, M., Sadachi, R., Shibata, T., Ichimura, M., Sakamoto, W., Hirata, Y., Nakamura, K., Yonemori, K.

Volltext

1521O A phase II biomarker-driven study evaluating the clinical efficacy of an MDM2 inhibitor, milademetan, in patients with intimal sarcoma, an ultra-rare cancer with highly life-... von Kojima, Y., Shimizu, T., Yonemori, K., Koyama, T., Matsui, N., Kamikura, M., Tomatsuri, S., Okuma, H.S., Shimoi, T., Noguchi, E., Sudo, K., Hirakawa, A., Sadachi, R., Okita, N.T., Nakamura, K., Yamamoto, N., Fujiwara, Y.

Volltext